leisure time -WSS

leisure time

author：comprehensive 2025-09-14 21:58:56 - browse：18

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

WSS

Pancreatic cancer early detection could be helped by AI

Medicare Advantage insurers face 0.2% cut to 2025 payments

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Humana’s losses in Medicare Advantage tank its stock

Wegovy leads to weight loss. Can it treat depression, too?

Reconstructing family trees of blood cells may help predict disease

focus

leisure time

knowledge

Psychedelics group wrestles with new pharma identity

Woman gored by Bison at Yellowstone

Drug repurposing or repositioning? The language matters

Medicare drug price negotiation legal challenge met with skepticism

As demand for Covid shots wanes, Moderna seeks its next success

Reconstructing family trees of blood cells may help predict disease

The cancer drug shortage isn’t new — and neither are the solutions

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Jerome Adams on the need for new antivirals for Covid

Medicare drug price negotiation legal challenge met with skepticism

explore

Vertex non

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Celiac disease study examines precisely how gluten triggers injury

Celiac disease study examines precisely how gluten triggers injury

Georgia court denies Trump's request to quash DA's 2020 election probe

Celiac disease study examines precisely how gluten triggers injury

entertainment

focus

hotspot

entertainment